Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Assets (2018 - 2025)

TransMedics (TMDX) has 8 years of Assets data on record, last reported at $1.1 billion in Q4 2025.

  • For Q4 2025, Assets rose 32.87% year-over-year to $1.1 billion; the TTM value through Dec 2025 reached $1.1 billion, up 32.87%, while the annual FY2025 figure was $1.1 billion, 32.87% up from the prior year.
  • Assets reached $1.1 billion in Q4 2025 per TMDX's latest filing, up from $946.0 million in the prior quarter.
  • Across five years, Assets topped out at $1.1 billion in Q4 2025 and bottomed at $117.3 million in Q2 2022.
  • Average Assets over 5 years is $526.6 million, with a median of $689.8 million recorded in 2023.
  • Peak YoY movement for Assets: decreased 17.68% in 2021, then soared 488.62% in 2023.
  • A 5-year view of Assets shows it stood at $134.9 million in 2021, then skyrocketed by 105.46% to $277.1 million in 2022, then soared by 154.76% to $706.0 million in 2023, then rose by 13.88% to $804.1 million in 2024, then surged by 32.87% to $1.1 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Assets were $1.1 billion in Q4 2025, $946.0 million in Q3 2025, and $890.5 million in Q2 2025.